PATENT CLAIM ANALYSIS

Application Number: 15866669
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["540", "465000"]

Abstract:
The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.

Claim (Index 6):
A theranostic system according to any one of  claims 3  to  5  wherein R 1f  represents a 2-methoxyphenyl, 2-bromophenyl, 2-fluorophenyl, 2-chlorophenyl, 3-methoxyphenyl, 3-bromophenyl, 3-fluorophenyl, 3-chlorophenyl, 3,5,difluorophenyl, 3,5,dichlorophenyl, 3,5,dibromophenyl, 3-(trifluoromethyl)phenyl, 4-chloro-3-(trifluoromethyl)phenyl, 3-chloro-4-fluorophenyl, 4-fluoro-3-(trifluoromethyl)phenyl, 4-fluorophenyl, 4-methoxyphenyl, 4-bromophenyl, 4-chlorophenyl, 4-isopropylphenyl, 3-bromo-5-(trifluoromethyl) phenyl, bis(trifluoromethyl)phenyl, 4-(tert-butl)phenyl or 1-napthylmethyl moiety.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.39394
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14751795', '10704120', '12209738', '11852604', '11807201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6468083866848059
- 35 USC 102 Novelty (BERT): 0.6374840582734818
- Combined Prediction Score: 0.6458759538436735
- Mean Citation Score: 314.902338
- Max Citation Score: 570.9696
- Similarity Product: 547.0132124450682

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test